Curetis Raised Additional €14.5M to Diagnose Severe Infectious Diseases
Curetis AG, a developer of next-level molecular diagnostic solutions, has closed a EUR 14.5 million extension of…
Curetis AG, a developer of next-level molecular diagnostic solutions, has closed a EUR 14.5 million extension of…
Theravalues Corporation, Tokyo based company, will launch Theracurmin® Super for the European market at Hi Europe 2014,…
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment…
The US pharmaceutical company Allergan, known for their Botox, agreed an Actavis bid of 53…
The biotech sector in the Greater Munich area continues to demonstrate significant growth in revenue…
Pharmaceutical giants Merck and Pfizer have agreed a deal to develop and market immunotherapy agents…
France has great Synthetic Biology Biotech companies. Paris-based Global Bioenergies carried out the first isobutene…
The French company Servier wants to invest one billion euros by a partnering with the…
Onxeo, an innovative company specializing in the development of orphan oncology drugs, founded after the…
Researchers at the Department of Biosystems in Basel have developed a novel gene regulation method that…
The title may seem a bit catchy, but that’s what lot of companies told me during…
Ziarco Group Ltd, a British biopharmaceutical start-up focusing on inflammatory skin diseases, bags €27M for…